The scoring systems in predicting short-term outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure

Ann Palliat Med. 2020 Sep;9(5):3048-3058. doi: 10.21037/apm-20-608. Epub 2020 Aug 20.

Abstract

Background: Hepatitis B virus related acute-on-chronic liver failure (HBV-ACLF) is a life-threatening syndrome characterized by acute and severe hepatic insults with high short-term mortality. This study aimed to compare the scoring systems which were used to predict short-term outcomes for HBV-ACLF patients.

Methods: A total of 529 patients diagnosed as HBV-ACLF were retrospectively analyzed and randomly divided, at a ratio of 3:1, into derivation cohort (n=397) and validation cohort (n=132). Univariate and multivariate analyses were performed to determine the discriminative abilities of the ALBI grade in predicting 30-day and 90-day mortality. The area under the receiver operating characteristic (AUC) curves was used to evaluate the accuracy of models.

Results: The survival was associated with lower ALBI score, MELD score and CLIF-C ACLF score than death. In the derivation cohort, elevated ALBI score was related to worse prognosis (30-day mortality: HR =3.452; 90-day mortality: HR =3.822), increased MELD score was associated with worse overall survival (30- day mortality: HR =1.073; 90-day mortality: HR =1.082), and increased CLIF-C ACLF score was associated with worse overall survival (30-day mortality: HR =1.061; 90-day mortality: HR =1.065). The multivariate analyses identified the ALBI score, MELD score and CLIF-C ACLF score as independent prognostic predictors. The results of validation cohort validated these findings.

Conclusions: Our study revealed that both the ALBI score, MELD score and CLIF-C ACLF score could predict 30- and 90-day mortality of HBV-ACLF accurately. Elevated ALBI score, MELD score and CLIF-C ACLF score were associated with worse prognosis.

Keywords: ALBI score; CLIF-C ACLF score; Hepatitis B virus related acute-on-chronic liver failure (HBV-ACLF); MELD score.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Acute-On-Chronic Liver Failure*
  • Hepatitis B virus*
  • Humans
  • Prognosis
  • ROC Curve
  • Retrospective Studies